REGN Exercise Disclosure
Fenimore Christopher R. · SEC Form 4 · Filed Nov 4, 2026
Exercise
Calculated transaction value
$2.29M
Fenimore Christopher R. EVP Finance CFO
REGN
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
REGN daily price context
Close on/before transaction
$961.26
Nov 2, 2026
First close after public filing
$902.9
Nov 5, 2026
Return after filing · so far
+0.16%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,000 shares @ $381.92
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001697422-26-000004
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$6.32M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN Current | Exercise | Nov 2, 2026 | $2.29M |
| Regeneron Pharmaceuticals, Inc. REGN | Disposition | Nov 2, 2026 | $4.03M |
| Regeneron Pharmaceuticals, Inc. REGN | Gift | Nov 2, 2026 | $0 |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 2, 2026 | $0 |